FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1873-1884 November 2, 2006 Number 18 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Renlund, D. G. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background In patients with severe heart failure, prolonged unloading of the myocardium with the use of a left ventricular assist device has been reported to lead to myocardial recovery in small numbers of patients for varying periods of time. Increasing the frequency and durability of myocardial recovery could reduce or postpone the need for subsequent heart transplantation.

Methods We enrolled 15 patients with severe heart failure due to nonischemic cardiomyopathy and with no histologic evidence of active myocarditis. All had markedly reduced cardiac output and were receiving inotropes. The patients underwent implantation of left ventricular assist devices and were treated with lisinopril, carvedilol, spironolactone, and losartan to enhance reverse remodeling. Once regression of left ventricular enlargement had been achieved, the ₂-adrenergic–receptor agonist clenbuterol was administered to prevent myocardial atrophy.

Results Eleven of the 15 patients had sufficient myocardial recovery to undergo explantation of the left ventricular assist device a mean (±SD) of 320±186 days after implantation of the device. One patient died of intractable arrhythmias 24 hours after explantation; another died of carcinoma of the lung 27 months after explantation. The cumulative rate of freedom from recurrent heart failure among the surviving patients was 100% and 88.9% 1 and 4 years after explantation, respectively. The quality of life as assessed by the Minnesota Living with Heart Failure Questionnaire score at 3 years was nearly normal. Fifty-nine months after explantation, the mean left ventricular ejection fraction was 64±12%, the mean left ventricular end-diastolic diameter was 59.4±12.1 mm, the mean left ventricular end-systolic diameter was 42.5±13.2 mm, and the mean maximal oxygen uptake with exercise was 26.3±6.0 ml per kilogram of body weight per minute.

Conclusions In this single-center study, we found that sustained reversal of severe heart failure secondary to nonischemic cardiomyopathy could be achieved in selected patients with the use of a left ventricular assist device and a specific pharmacologic regimen.

Source Information

From the Royal Brompton and Harefield National Health Service Trust, Harefield, Middlesex, United Kingdom (E.J.B., P.D.T., J.H., R.S.G., C.T.B., M.B., N.R.B., A.K., M.H.Y.); and the Heart Science Centre, National Heart and Lung Institute, Imperial College, London (E.J.B., P.D.T., J.H., R.S.G., C.T.B., A.K., M.H.Y.).

Address reprint requests to Dr. Yacoub at the Heart Science Centre, Royal Brompton and Harefield Hospital, Harefield, Middlesex UB9 6JH, United Kingdom, or at m.yacoub{at}ic.ac.uk.

Full Text of this Article

Related Letters:

Left Ventricular Assist Devices and Drug Therapy in Heart Failure
Hetzer R., Dandel M., Knosalla C., Burniston J. G., Florea V. G., Rott D., Leibowitz D., Vanderwilt G. J., Yacoub M. H., Birks E. J.
Extract | Full Text | PDF  
N Engl J Med 2007; 356:869-872, Feb 22, 2007. Correspondence

This article has been cited by other articles:

• Braunwald, E. (2008). The Management of Heart Failure: The Past, the Present, and the Future. Circ Heart Fail 1: 58-62 [Full Text]  
• Lynch, G. S., Ryall, J. G. (2008). Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease. Physiol. Rev. 88: 729-767 [Abstract] [Full Text]  
• BEYAR, R. (2008). Controlling Ischemic Cardiovascular Disease: From Basic Mechanisms to Clinical Management. Ann. N. Y. Acad. Sci. 1123: 232-236 [Abstract] [Full Text]  
• Soppa, G. K.R., Lee, J., Stagg, M. A., Felkin, L. E., Barton, P. J.R., Siedlecka, U., Youssef, S., Yacoub, M. H., Terracciano, C. M.N. (2008). Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure. Cardiovasc Res 77: 695-706 [Abstract] [Full Text]  
• Haj-Yahia, S., Birks, E.J., Dreyfus, G., Khaghani, A. (2008). Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery.. J. Thorac. Cardiovasc. Surg. 135: 453-454 [Full Text]  
• Kooshkabadi, M., Kalogeropoulos, A., Babaliaros, V. C., Lerakis, S. (2008). Transesophageal guided left atrial positioning of a percutaneous ventricular assist device. Eur J Echocardiogr 9: 175-177 [Abstract] [Full Text]  
• Davies, R. R. (2007). Invited commentary. Ann. Thorac. Surg. 84: 1262-1263 [Full Text]  
• Shuros, A. C., Salo, R. W., Florea, V. G., Pastore, J., Kuskowski, M. A., Chandrashekhar, Y., Anand, I. S. (2007). Ventricular Preexcitation Modulates Strain and Attenuates Cardiac Remodeling in a Swine Model of Myocardial Infarction. Circulation 116: 1162-1169 [Abstract] [Full Text]  
• Mau, J., Menzie, S., Ward, M., Bundgaard, H., Hunyor, S. (2007). Time-dependent response of both ventricles after septal ablation: Implications for biventricular support after left ventricular assist device placement. J. Thorac. Cardiovasc. Surg. 134: 579-586 [Abstract] [Full Text]  
• Hunt, S. A. (2007). Mechanical Circulatory Support: New Data, Old Problems. Circulation 116: 461-462 [Full Text]  
• Haykowsky, M. J., Liang, Y., Pechter, D., Jones, L. W., McAlister, F. A., Clark, A. M. (2007). A Meta-Analysis of the Effect of Exercise Training on Left Ventricular Remodeling in Heart Failure Patients: The Benefit Depends on the Type of Training Performed. J Am Coll Cardiol 49: 2329-2336 [Abstract] [Full Text]  
• Maybaum, S., Mancini, D., Xydas, S., Starling, R. C., Aaronson, K., Pagani, F. D., Miller, L. W., Margulies, K., McRee, S., Frazier, O.H., Torre-Amione, G., for the LVAD Working Group, (2007). Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group. Circulation 115: 2497-2505 [Abstract] [Full Text]  
• Jones, R. H. (2007). The Year in Cardiovascular Surgery. J Am Coll Cardiol 49: 1887-1898 [Full Text]  
• Milbrandt, E. B., Ishizaka, A., Angus, D. C. (2007). Update in Critical Care 2006. Am. J. Respir. Crit. Care Med. 175: 638-648 [Full Text]  
• TERRACCIANO, C. M. N., KOBAN, M. U., SOPPA, G. K., SIEDLECKA, U., LEE, J., STAGG, M. A., YACOUB, M. H. (2007). The Role of the Cardiac Na+/Ca2+ Exchanger in Reverse Remodeling: Relevance for LVAD-Recovery. Ann. N. Y. Acad. Sci. 1099: 349-360 [Abstract] [Full Text]  
• Hall, J. L., Birks, E. J., Grindle, S., Cullen, M. E., Barton, P. J., Rider, J. E., Lee, S., Harwalker, S., Mariash, A., Adhikari, N., Charles, N. J., Felkin, L. E., Polster, S., George, R. S., Miller, L. W., Yacoub, M. H. (2007). Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 28: 613-627 [Abstract] [Full Text]  
• Lowes, B. D., Baker, M. L., Blaxall, B. C. (2007). Gene expression profile of the recovering human heart. Eur Heart J 28: 522-524 [Full Text]  
• Lindsay, A. (2007). JournalScan. Heart 93: 409-410 [Full Text]  
• Hetzer, R., Dandel, M., Knosalla, C., Burniston, J. G., Florea, V. G., Rott, D., Leibowitz, D., Vanderwilt, G. J., Yacoub, M. H., Birks, E. J. (2007). Left Ventricular Assist Devices and Drug Therapy in Heart Failure. NEJM 356: 869-872 [Full Text]  
• (2006). End stage heart failure may be reversible. BMJ 333: 1014-1014 [Full Text]  
• Renlund, D. G., Kfoury, A. G. (2006). When the Failing, End-Stage Heart Is Not End-Stage. NEJM 355: 1922-1925 [Full Text]  
• (2006). Can an LVAD plus Drugs Reverse Advanced Systolic Heart Failure?. Journal Watch Cardiology 2006: 2-2 [Full Text]